ArticleDiscover oncology2023

ABHD17C, a metabolic and immune-related gene signature, predicts prognosis and anti-PD1 therapy response in pancreatic cancer.

Weihao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.